Free Trial
→ Post-Halving = Profit Season (Here’s How to Win It) (From Crypto Swap Profits) (Ad)

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ATT
Abattis Bioceuticals
C$0.00
C$0.05
▼
C$0.74
N/AN/A1.42 million shsN/A
DIG
ProShares Ultra Energy
$35.08
+0.5%		$32.80
$26.50
▼
$47.04
$78.69M2.6866,628 shs28,900 shs
20 Stocks to Sell Now Cover
20 Stocks to Sell Now

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ATT
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
DIG
ProShares Ultra Energy
0.00%+4.16%+13.16%+17.88%-17.32%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
DIG
ProShares Ultra Energy
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ATT
Abattis Bioceuticals
0.00
N/AN/AN/A
DIG
ProShares Ultra Energy
2.63
Moderate Buy$35.08N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/A
DIG
ProShares Ultra Energy
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ATT
Abattis Bioceuticals
N/AN/A0.00N/AN/AN/AN/AN/AN/A
DIG
ProShares Ultra Energy
N/AN/A14.85∞N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/A
DIG
ProShares Ultra Energy
$1.042.96%N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
ATT
Abattis Bioceuticals
N/A
DIG
ProShares Ultra Energy
N/A

Insider Ownership

CompanyInsider Ownership
ATT
Abattis Bioceuticals
N/A
DIG
ProShares Ultra Energy
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
ATT
Abattis Bioceuticals
N/AN/AN/ANot Optionable
DIG
ProShares Ultra Energy
N/A2.25 millionN/ANot Optionable

Recent News About These Companies

(DIG) | Stock Price & Latest News | Reuters
June 24, 2025  |  reuters.comhttps://www.reuters.com/markets/quote/DIG/
Leveraged Energy ETFs to Tap Oil Price Surge
June 23, 2025  |  zacks.comhttps://www.zacks.com/stock/news/2536330/leveraged-energy-etfs-to-tap-oil-price-surge?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2536330
ProShares Ultra MSCI EAFE declares quarterly distribution of $0.1360
March 27, 2025  |  msn.comhttps://www.msn.com/en-us/money/other/proshares-ultra-msci-eafe-declares-quarterly-distribution-of-01360/ar-AA1BNpIh
ProShares S&P 500 Ex-Energy ETF declares quarterly distribution of $0.1641
March 27, 2025  |  msn.comhttps://www.msn.com/en-us/money/topstocks/proshares-s-p-500-ex-energy-etf-declares-quarterly-distribution-of-01641/ar-AA1BNExu
(DIG) Trading Advice
February 15, 2025  |  news.stocktradersdaily.comN
(DIG) Pivots Trading Plans and Risk Controls
February 2, 2025  |  news.stocktradersdaily.comN
Oil Logs Big Weekly Gain in a Year: Leveraged Energy ETFs Surge
October 7, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2346842/oil-logs-big-weekly-gain-in-a-year-leveraged-energy-etfs-surge?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2346842
When (DIG) Moves Investors should Listen
September 27, 2024  |  news.stocktradersdaily.comN
How the (DIG) price action is used to our Advantage
September 1, 2024  |  news.stocktradersdaily.comN
DIG ProShares Ultra Energy ETF
August 29, 2024  |  seekingalpha.comhttps://seekingalpha.com/symbol/DIG/risk
Trading (DIG) With Integrated Risk Controls
August 9, 2024  |  news.stocktradersdaily.comN
Proshares Ultra Euro Share Price (ULE.US)
August 2, 2024  |  lse.co.ukhttps://www.lse.co.uk/SharePrice.html?shareprice=ULE.US
Learn to Evaluate (DIG) using the Charts
July 28, 2024  |  news.stocktradersdaily.comN
Pick Leveraged ETFs to Tap Surging Oil Prices
April 9, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2252747/pick-leveraged-etfs-to-tap-surging-oil-prices?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2252747
ProShares Ultra S&P500 ETF: Fear Not The All-Time High
March 19, 2024  |  seekingalpha.comhttps://seekingalpha.com/article/4679060-proshares-ultra-sp500-etf-fear-not-all-time-high
ProShares Ultra FTSE China 50 (XPP)
February 24, 2024  |  investing.comhttps://www.investing.com/etfs/proshares-ultra-xinhua-china-25
23 ultra-processed foods you should avoid
February 21, 2024  |  msn.comhttps://www.msn.com/en-za/health/other/23-ultra-processed-foods-you-should-avoid/ss-BB1iFllq
ProShares Ultra Oil & Gas (DIG)
February 12, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/quote/DIG/history
DIG ETF: Caution Due To Economic Risks
October 25, 2023  |  msn.comhttps://www.msn.com/en-us/money/markets/dig-etf-caution-due-to-economic-risks/ar-AA1iQoRz
The Zacks Analyst Blog Highlights DIG, ERX, GUSH, NRGU and OILU
October 10, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/zacks-analyst-blog-highlights-dig-122700614.html

Media Sentiment Over Time

Top Headlines

View All Headlines

Abattis Bioceuticals CNSX:ATT

Abattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.

ProShares Ultra Energy NYSEARCA:DIG

$35.08 +0.18 (+0.52%)
As of 07/3/2025 05:00 PM Eastern

ProShares Ultra Oil & Gas (the fund) seeks daily investment results that correspond to twice (200%) the daily performance of the Dow Jones U.S. Oil & Gas Index (the Index). The Fund intends to invest at least 80% of its net assets, including any borrowings for investment purposes, under normal circumstances, to equity securities contained in the Index and/or financial instruments that, in combination, have similar economic characteristics. The Fund also intends to invest assets not invested in financial instruments, in debt instruments and/or money market instruments. The Fund intends to concentrate its investments in a particular industry or group of industries to approximately the same extent as the Index is so concentrated. ProShare Advisors LLC serves as the investment advisor to the Fund.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas